Venture Global LNG on Wednesday slashed the valuation it sought from a U.S. initial public offering to $65.33 billion, significantly lower than the initial target of $110 billion. The revision by the second-largest exporter of liquefied natural gas in the United States follows days of marketing to potential investors,

Venture Global is now seeking a more reasonable valuation of about $65 billion, versus earlier plans for about $110 billion.

The company plans to increase its share offering from 50 million to up to 62 million in its potential New York flotation.

Venture Global LNG was forced to nearly halve the valuation it is seeking in its U.S. initial public offering (IPO) after investors balked at the company's estimated long-term profit for liquefying gas for export,

LNG exporter Venture Global nearly halved the price per share, while increasing the number of shares it expects to offer.

US-based Venture Global LNG is set to formally engage investors for its initial public offering (IPO), targeting a valuation of $110bn, reported Reuters, citing a document and a person familiar with the matter.

Venture Global LNG is preparing to cut the proposed price range for its blockbuster initial public offering and increase the number of shares it may sell to investors, a source with direct knowledge of the matter said on Tuesday.

The IPO documents show Venture Global has raised about $54bn to build its terminals and pay operating expenses since it was founded 11 years ago. It has earned nearly $20bn in gross proceeds over that time, while long-term contracts are expected to generate revenues of $107bn in coming years.

Drugs Made in America Acquisition (DMAAU) is a healthcare-focused blank check company raising $200.7M through IPO this week at $10.00 per share.